Untitled Document
Not a member yet? Register for full benefits!

 European Unions Approves Deep Brain Stimulation Systems for Parkinson's

This story is from the category The Brain
Printer Friendly Version
Email to a Friend (currently Down)



Date posted: 30/01/2009

European regulators have given a green light to St. Jude Medical to market the company's Libra? and LibraXP deep brain stimulation (DBS) systems for treatment of symptoms of Parkinson's disease.

The Libra DBS systems function in a manner similar to a heart pacemaker by delivering mild electrical pulses from an implanted device to stimulate structures in the brain that are involved in muscle and movement control. Stimulation is delivered to one of two regions in the brain known as the subthalamic nucleus (STN) or the globus pallidus interna (GPi) to influence nerve cell activity in these regions.

"The approval of our first deep brain stimulation system represents the fulfillment of a milestone for St. Jude Medical as we continue to deliver on our promise to develop therapies to treat neurological conditions," said Chris Chavez, president of the St. Jude Medical Neuromodulation Division.

See the full Story via external site: phx.corporate-ir.net

Most recent stories in this category (The Brain):

04/02/2017: HKU scientists utilise innovative neuroimaging approach to unravel complex brain networks

26/01/2017: Personality linked to 'differences in brain structure'

12/01/2017: Donkey Kong used to Help Guide New Approaches in Neuroscience

10/12/2016: Doctors use deep-brain ultrasound therapy to treat tremors

17/02/2015: Hearing experts break sound barrier for children born without hearing nerve

17/02/2015: Smoking thins vital part of brain

05/02/2015: Intracranial Stimulation Proved Efficient in the Recovery of Learning and Memory in Rats

05/02/2015: Repeated head blows linked to smaller brain volume and slower processing speeds